Moderna says trials show its COVID-19 vaccine is effective in kids as young as 12
FOX 4 Now Florida
Moderna said Tuesday that Phase 2 trial results show that its COVID-19 vaccine is effective in adolescents aged 12 to 17.
Moderna said Tuesday that Phase 2 trial results show that its COVID-19 vaccine is effective in adolescents aged 12 to 17.
Cambridge-based Moderna says its vaccine is very effective in protecting kids against COVID-19.
The U.S. Food and Drug Administration is preparing to authorize Pfizer Inc and German partner BioNTech SE's COVID-19 vaccine for..